CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jilin Jian Yisheng Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jilin Jian Yisheng Pharmaceutical Co Ltd
No. 17-20, Wenhua East Road, Ji'an City
Phone: +86 4356236009p:+86 4356236009 TONGHUA, JLN  134200  China Ticker: 002566002566
Business Summary
Jilin Jian Yisheng Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceutical products. The Company’s business covers the entire ginseng industry chain, including ginseng cultivation, traditional Chinese medicine manufacturing, health products, cosmetics, honey products, and packaging printing. The Company’s products include modern Chinese medicines made from ginseng and American ginseng, such as Zhenyuan Capsules, Xinyue Capsules, Shengmai Injection and Xiaozhiling Injection, as well as ginseng-based health foods, skincare products, and other related products. The Company mainly conducts its businesses within domestic market.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board YishengZhang 59 12/28/2000 12/28/2000
Vice Chairman of the Board XinZhang 34 5/11/2022 5/11/2022
Chief Financial Officer, Deputy General Manager, Director JiantaoBi 52 5/11/2022 8/1/2011
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,656 (As of 12/31/2024)
Outstanding Shares: 330,951,600 (As of 9/30/2025)
Shareholders: 20,492
Stock Exchange: SHE
Fax Number: +86 4356236009


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, December 4, 2025